We previously showed that estrogen receptor (ER) mRNA is present in preimplantation mouse embryos. The apparent synthesis of ER mRNA by the blastocyst at the time of implantation when estrogen is required was of special interest. A demonstration of the presence of ER protein would support the idea that estrogen can act directly on the embryo.
early egg cylinder stage, continued expression of ER was observed in cells derived from the inner cell mass or the trophoblast. In trophoblast giant cells, ER was concentrated in small regions of the nucleus, possibly the nucleoli, which was similar to that observed in dormant and activated blastocysts. The embryonic expression of ER at such early stages in a broad array of cells suggests that ER may have a general role during early development.
Estrogen receptor (ER) mRNA is present in preimplantation mouse embryos (1) . Interestingly, ER mRNA was detected at the blastocyst stage and was likely of embryonic and not maternal origin. Mouse embryos implant at the blastocyst stage and estrogen is an absolute requirement for this process. In the mouse, blastocysts become dormant and implantation is delayed in ovariectomized mice receiving progesterone only (2) . After an estrogen injection, the dormant blastocysts become reactivated and implantation resumes (3, 4) . Changes occur in blastocyst metabolism including RNA and protein synthesis in response to estrogen treatment (3) (4) (5) (6) . There are two possible ways that estrogen can influence the blastocyst. One is to induce changes in the uterus, which in turn produce signals that the blastocyst recognizes. Estrogen-induced uterine changes have been well documented (7) . The second possibility is the direct effect(s) of estrogen on the blastocyst. The existence of this latter pathway is controversial. Since estrogen elicits its functions primarily through its receptor protein, the ER, a direct estrogen effect on the blastocyst should require the presence of ER protein in the blastocyst. The presence of ER mRNA in the blastocyst only indicates that the ER gene is being transcribed; it does not guarantee the expression of ER protein. A direct demonstration of ER expression at the protein level is required.
The preimplantation mouse blastocyst contains 32-64 cells (8) and is differentiated into two cell types: the trophectoderm, which contributes to extraembryonic tissues, and the inner cell
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. 2376 mass, from which the fetus is derived. On the evening of the third day of pregnancy (vaginal plug = 0.5 day), the blastocyst adheres to the luminal epithelium of the uterus. The trophoblast cells later interdigitate with the epithelial cells and eventually invade the uterus, forming a three-dimensional structure that interlocks with the inner cell mass (9, 10) . The inner cell mass continues to proliferate. Determination of the status of ER expression during this period would be informative. If the ER's role is only to prepare for implantation, ER expression should cease at this time. However, if ER has a more general function, its expression should continue.
To examine whether ER is expressed in the implanting blastocyst, we employed in vitro culture systems. These systems have been used by others to mimic certain aspects of postimplantation embryonic development (10) (11) (12) (13) . In contrast to an implanting blastocyst in utero, the trophoblast and inner cell mass spread out on the flat plastic substrate during in vitro development. Subsequently, a three-dimensional egg cylinder grows out of the inner cell mass without the surrounding trophoblast barrier. Although the development of in vitrocultured embryos is slower compared with its in vivo counterpart, light and electron microscopic studies show that the development of the embryo proper is apparently comparable to normal development (10) .
In this study, we employed immunocytochemistry to examine the cell-type-specific distribution of ER protein in normal, delayed, and activated blastocysts, as well as the fate of ER in the implanting blastocyst in vitro. Our finding that ER is present in both the inner cell mass and trophectoderm cells in the blastocyst and that ER expression persists at least until the early egg cylinder stage in all cell types suggests that ER may be important for implantation and/or early embryogenesis. This is paradoxical to the finding that "knockout" mice with disrupted ER genes are viable, which argues that ER may not be needed for early development (14) .
MATERIALS AND METHODS
Embryo Recovery. CD-1 female mice (48 days old) were mated with males of the same strain to induce pregnancy (vaginal plug = 0.5 day). Embryos at different stages of development were recovered in Whitten's medium by flushing the reproductive tract (15) .
Delayed implantation was induced by ovariectomizing adult mice on day 3 of pregnancy. To maintain delayed implantation, ovariectomized mice were injected with progesterone (2 mg per mouse in 0.1 ml of sesame oil, s.c.) from days 4.5 to 6.5. To terminate delayed implantation, mice were given an injection of 17f3-estradiol (25 Blastocysts were collected in Whitten's medium (15) . Dormant blastocysts were recovered from ovariectomized mice after 18 h of progesterone injection, whereas activated blastocysts were recovered 18 h after an injection of estradiol and progesterone on day 6.5.
Culturing Fertilized Eggs to Blastocysts. The procedure for culturing fertilized eggs to blastocysts was as described by Hogan et al. (8) . Briefly, female C57BL/6 mice (HarlanSprague-Dawley) were superovulated by injecting 5 international units of pregnant mare's serum gonadotropin (Diosynth, Chicago), followed by 5 international units of human chorionic gonadotropin (Organon) 48 h later. These females were placed with males after human chorionic gonadotropin injection. Mated female mice were sacrificed the following day around noon (day 0.5). Embryos were recovered from the oviducts, stripped of adhering cumulus cells, and cultured in M16 medium under light mineral oil at 37°C in 5% CO2/95% air in a humidified incubator. The day the embryos were placed in M16 culture medium was defined as day 0. After 4 days of culture, most of the blastocysts were expanded and some were exhibiting zona hatching.
Cultured blastocysts used for immunocytochemistry were collected at noon on day 4 and freed of zona pellucida by a brief exposure to acidified bovine serum albumin (BSA)-free M2 medium (pH 2.5). Zona-free blastocysts were then washed thoroughly in BSA-free M2 medium and attached to chrom alum/gelatin and poly(L-lysine) (Sigma)-coated coverslips. In utero-developed normal blastocysts were recovered at 0900 h on day 3 and subjected to a brief Pronase treatment for dissolution of zona pellucida (15) . Day 3 normal, day 7 dormant, and day 7 activated blastocysts were cytospun onto poly(L-lysine)-coated slides for immunostaining.
Culturing Embryos Beyond the Blastocyst Stage. The procedure for culturing embryos beyond the blastocyst stage was modified from a combination of protocols (10, 12, 13, 16) . CMRL medium 1066 containing 1 mM glutamine (GIBCO/ BRL), supplemented with freshly made 1 mM sodium pyruvate (Sigma) and 20% fetal bovine serum was used on the day blastocysts were placed in culture. This complete medium was stored at 4°C for subsequent feeding up to 3 days.
Blastocysts were obtained by culturing fertilized eggs as described above, except the culture medium was phenol redfree. On the morning of day 4 in M16 medium, blastocysts were transferred to four-well chamber plastic slides (Permanox, Nunc) filled with culture medium. The day blastocysts were placed into the serum-containing medium was defined day 0 of transfer. Embryos were fed on the mornings of days 2 and 3 of transfer. During the first day after transfer, most blastocysts had shed their zona pellucidae and adhered to the plastic slides. Between 1 and 2 days after transfer, the mural trophoblast cells migrated out radially on the plastic surface. By the morning of day 4, an egg cylinder could be seen as a raised compact portion pointing to the medium over the trophoblast cells. Trophoblast cells that had transformed to giant cells were distinct by their large size.
Immunocytochemistry. Essentially similar procedures were used for normal and dormant blastocysts and embryos that were cultured beyond the blastocyst stage in vitro. In general, embryos were washed in ice-cold phosphate-buffered saline (PBS). They were then fixed in chilled 4% (vol/vol) formaldehyde in PBS for 10-20 min and permeabilized with PBS containing 0.1 or 0.2% Triton X-100 for 3-5 min. Embryos were incubated first in the blocking solution (PBS/3% BSA/ 0.2% Tween 20/0.1 M glycine) for 3 h, followed by further incubation in PBS containing 10% (vol/vol) goat serum (Sigma), 0.2% Tween 20, and 0.02% sodium azide at 4°C overnight.
After blocking, ER 715 or its controls diluted in the second blocking solution were added and incubated at 4°C overnight. ER 715 is a specific antibody to the ER that was developed in a rabbit against a synthetic peptide corresponding to the hinge region of the ER (17) . ER 715 was used at 40-150 ng/ml. The controls included blocking solution without primary antibody, nonimmune rabbit IgG (500 ng/ml) (Sigma), and ER 715 preabsorbed with 6000-fold excess of the peptide. Embryos were washed with PBS containing 3% BSA and 0.2% Tween 20, followed by incubation at 4°C for 2 h or overnight with horseradish peroxidase-conjugated goat anti-rabbit antibody (Vector Laboratories) at 0.5-2 ,g/ml in the same buffer or the second blocking solution. Embryos were washed. Embryos older than the blastocyst underwent an additional wash with PBS containing 0.1% Triton X-100 and 0.2% BSA for 20 min. A substrate of 3,3'-diaminobenzidine tetrahydrochloride (Polyscience; 0.5 mg/ml) and 0.02% H202 (Aldrich) in 50 mM Tris HCl (pH 7) was added to the embryos. Older embryos were incubated in 3,3'-diaminobenzidine tetrahydrochloride solution for 20 min before the addition of H202. The reaction was allowed to proceed until color was apparent, which required 1-20 min and was terminated by rinsing in H20 or PBS/0.1% Triton X-100/0.2% BSA. Blastocysts on coverslips were mounted with Crystal mount (Biomedia, Foster City, CA) and postmounted on slides with Polymount (Polyscience).
The chamber slides on which blastocysts were cultured for 2 days were mounted with Crystal mount and coverslipped with Polymount. Early egg cylinder stage embryos, cultured for 4 days from the blastocyst stage, were dehydrated through graded methanol and stored in methanol at -20°C until photographed. Immunostaining of ER in in utero-developed day 3 normal, day 7 dormant, and day 7 activated blastocysts was performed by using a Zymed histostain-SP kit specific to rabbit antibodies (Zymed) containing a biotinylated secondary antibody, a horseradish-streptavidin conjugate, and a substrate-chromogen mixture (15 tive ER was present in both the trophectoderm and inner cell mass cells (Fig. 2) . In the trophectoderm of dormant blastocysts, the staining was primarily evident in a few areas within the nucleus, suggesting accumulation of ER in the nucleolus. Preabsorption of the antibody with the peptide completely abolished the immunostaining.
ER Expression in Implanting Blastocysts in Vitro. After 2 days of culture in the complete serum-containing medium, the blastocyst attached to the bottom of and the trophoblast cells migrated outward on the plastic slides. At this stage, similar to that of the unattached blastocyst, nuclear staining was observed in all cells of both the inner cell mass and the trophoblast cells when immunostaining was performed with the antibody ER 715 (Fig. 3) . The staining was specific, since it was undetectable when ER 715 was preabsorbed with the ER peptide. This result indicates that both cell types continue to express ER at this stage.
ER Distribution at the Early Egg Cylinder Stage. The inner cell mass continues to grow after attachment of the blastocyst. On day 4 of culture in the serum-containing medium, a raised portion of compact cells resembling an early egg cylinder was clearly visible. Trophoblast giant cells derived from mural trophoblast cells that spread on the slide were also distinct. Staining was observed with the ER 715 antibody in both portions (Fig. 4) and the specificity was verified with the preabsorbed antibody.
Contrary to the staining observed in the attached and unattached blastocysts, immunostaining in trophoblast giant cells was no longer distributed throughout the nucleus. Instead, a few spots of dense staining were visible, indicating a localization of ER inside the nucleus (Fig. 4) . It seems possible that the dense spots correspond to the nucleoli. This pattern of staining was similar to that observed in the dormant blastocyst. It is not known why ER stimulated by estrogen in delayed blastocysts upon estrogen treatment (22) . Changes in the morphology of the nucleoli have also been reported (9) . The localization of ER in the nucleoli is consistent with these observations. (ii) The (9) . Estrogen-induced changes in the expression of cell surface proteins occur around the time of implantation (6) . Such would be expected to be embryonic lethal. There is only a single report of a naturally occurring ER mutation (25) . The mutation carrier is a male with tall stature associated with incomplete closure of the epiphyses. The extreme rarity of such mutations suggests that ER may be required for embryonic survival. It is therefore surprising that ER-null mice created by insertional mutation were viable (14) . These mice are infertile and have abnormal reproductive tracts. Interestingly, the uteri of these mice still contain 5-10% of normal estrogen binding capacity. It is possible that residual ERs exist in these mice. The essential functions of ER for survival may be carried out by these residual receptors. Alternatively, redundant regulatory pathways may exist. In the absence of ER, another protein(s) may substitute for ER.
It is possible that ER expression in early development is only necessary for its continued expression or function in later development but has no role during the pre-or periimplantation period. Perhaps during development, ER is expressed in every cell at early times such as the blastocyst stage, and then some cells gradually lose ER. The changes in ER distribution in dormant blastocysts and the trophoblast giant cells in in vitro early egg cylinders may be examples of ER loss in progress. By the time of adulthood, only certain tissues retain ER. This process of expressing ER in all cells initially and restricting receptor expression in a majority of cells later may be necessary if ER is to execute its function at both early and later times. It has been observed that stable transfection, rather than transient transfection, of ER into ER-negative cells is needed for ER to induce certain estrogen-responsive endogenous genes (26) . Similar phenomena have also been reported for the progesterone receptor (27) . A prolonged existence of ER may be required for its participation in chromatin modeling and the receptor's access to specific target DNA. During the course of development, this requirement for the prolonged presence of ER is probably reflected by its expression very early in development. It will be interesting to see whether a normal response to estrogen could be fully recovered if ER is reintroduced into the ER "knockout" mice sometime later in development or in cell lines derived from the adult mutant mice.
